Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity
- PMID: 26608630
- DOI: 10.4155/tde.15.73
Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity
Abstract
Ophthalmic diseases collect great attention by researchers and pharmaceutical technologists, since they can dramatically worsen the quality of life. Because of the limited duration of action on the eye surface, and anatomical/physiological barriers to drug penetration from it into the inner eye structures, conventional ocular formulations are generally unable to perform at their best. Nanotechnology approaches can represent a solution to improve the therapeutic efficiency, compliance and safety of ocular drugs. In this respect, lipid-based nanocarriers are among the most interesting systems. Their composition and production methods make them highly biocompatible and safe formulations. This review illustrates the developments achieved in ocular drug delivery using lipid-based nanocarriers, with a critical revision of recent scientific articles and filed patents.
Similar articles
-
Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers.Drug Discov Today. 2013 Mar;18(5-6):290-7. doi: 10.1016/j.drudis.2012.10.005. Epub 2012 Oct 22. Drug Discov Today. 2013. PMID: 23092895 Review.
-
Pharmaceutical and biomedical applications of lipid-based nanocarriers.Pharm Pat Anal. 2014 Mar;3(2):199-215. doi: 10.4155/ppa.13.79. Pharm Pat Anal. 2014. PMID: 24588596 Review.
-
Lipid nanoparticles as drug/gene delivery systems to the retina.J Ocul Pharmacol Ther. 2013 Mar;29(2):173-88. doi: 10.1089/jop.2012.0128. Epub 2013 Jan 3. J Ocul Pharmacol Ther. 2013. PMID: 23286300 Review.
-
Designing lipid nanoparticles for topical ocular drug delivery.Int J Pharm. 2017 Oct 30;532(1):204-217. doi: 10.1016/j.ijpharm.2017.09.017. Epub 2017 Sep 8. Int J Pharm. 2017. PMID: 28893582 Review.
-
Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective.Recent Pat Drug Deliv Formul. 2019;13(4):246-254. doi: 10.2174/1872211314666191224115211. Recent Pat Drug Deliv Formul. 2019. PMID: 31884933 Free PMC article. Review.
Cited by
-
Recent perspectives on the delivery of biologics to back of the eye.Expert Opin Drug Deliv. 2017 May;14(5):631-645. doi: 10.1080/17425247.2016.1227783. Epub 2016 Sep 6. Expert Opin Drug Deliv. 2017. PMID: 27573097 Free PMC article. Review.
-
Lipid Nanoparticles Traverse Non-Corneal Path to Reach the Posterior Eye Segment: In Vivo Evidence.Molecules. 2021 Aug 2;26(15):4673. doi: 10.3390/molecules26154673. Molecules. 2021. PMID: 34361825 Free PMC article.
-
Recent Advances in Nanotechnology for the Treatment of Dry Eye Disease.Nanomaterials (Basel). 2024 Apr 12;14(8):669. doi: 10.3390/nano14080669. Nanomaterials (Basel). 2024. PMID: 38668163 Free PMC article. Review.
-
Relevance of Lipid-Based Products in the Management of Dry Eye Disease.J Ocul Pharmacol Ther. 2017 Nov;33(9):647-661. doi: 10.1089/jop.2017.0052. Epub 2017 Sep 28. J Ocul Pharmacol Ther. 2017. PMID: 28956698 Free PMC article. Review.
-
A Method for Efficient Loading of Ciprofloxacin Hydrochloride in Cationic Solid Lipid Nanoparticles: Formulation and Microbiological Evaluation.Nanomaterials (Basel). 2018 May 6;8(5):304. doi: 10.3390/nano8050304. Nanomaterials (Basel). 2018. PMID: 29734771 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources